216 related articles for article (PubMed ID: 28742793)
41. Twist mediates an aggressive phenotype in human colorectal cancer cells.
Deng JJ; Zhang W; Xu XM; Zhang F; Tao WP; Ye JJ; Ge W
Int J Oncol; 2016 Mar; 48(3):1117-24. PubMed ID: 26782761
[TBL] [Abstract][Full Text] [Related]
42. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
43. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
[TBL] [Abstract][Full Text] [Related]
44. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
[TBL] [Abstract][Full Text] [Related]
45. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
46. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
47. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
48. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
Wey JS; Fan F; Gray MJ; Bauer TW; McCarty MF; Somcio R; Liu W; Evans DB; Wu Y; Hicklin DJ; Ellis LM
Cancer; 2005 Jul; 104(2):427-38. PubMed ID: 15952180
[TBL] [Abstract][Full Text] [Related]
49. Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.
Fan F; Samuel S; Gaur P; Lu J; Dallas NA; Xia L; Bose D; Ramachandran V; Ellis LM
Br J Cancer; 2011 Apr; 104(8):1270-7. PubMed ID: 21407219
[TBL] [Abstract][Full Text] [Related]
50. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
51. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
52. VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
Tomida C; Yamagishi N; Nagano H; Uchida T; Ohno A; Hirasaka K; Nikawa T; Teshima-Kondo S
Int J Oncol; 2018 Apr; 52(4):1350-1362. PubMed ID: 29532881
[TBL] [Abstract][Full Text] [Related]
53. XB130 enhances invasion and migration of human colorectal cancer cells by promoting epithelial‑mesenchymal transition.
Shen J; Jin C; Liu Y; Rao H; Liu J; Li J
Mol Med Rep; 2017 Oct; 16(4):5592-5598. PubMed ID: 28849225
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
[TBL] [Abstract][Full Text] [Related]
55. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
Wang F; Ruan XJ; Zhang HY
Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
[TBL] [Abstract][Full Text] [Related]
56. High PGD
Dash P; Ghatak S; Topi G; Satapathy SR; Ek F; Hellman K; Olsson R; Mehdawi LM; Sjölander A
Br J Cancer; 2022 Mar; 126(4):586-597. PubMed ID: 34750492
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
58. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
59. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
60. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]